BL
IMMX icon

Bleichroeder LP’s Immix Biopharma IMMX Stock Holding History

Bleichroeder LP’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3M Hold
1,000,000
– – 1.84% 10
2026
Q1 		$9.11M Hold
1,000,000
– – 1.57% 12
2025
Q4 		$5.23M Buy
1,000,000
+150,000
+18% +$617K 0.92% 14
2025
Q3 		$1.78M Hold
850,000
– – 0.35% 29
2025
Q2 		$1.76M Hold
850,000
– – 0.43% 24
2025
Q1 		$1.43M Hold
850,000
– – 0.38% 25
2024
Q4 		$1.87M Hold
850,000
– – 0.47% 22
2024
Q3 		$1.27M Hold
850,000
– – 0.34% 29
2024
Q2 		$1.68M Hold
850,000
– – 0.5% 23
2024
Q1 		$2.61M Buy
+850,000
New +$3.29M 0.65% 21

Other funds holding IMMX

JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bleichroeder LP's IMMX Position: Q2 2026 in Review

Bleichroeder LP held its Immix Biopharma (IMMX) position steady in Q2 2026 at 1,000,000 shares worth $10.3M. The position accounts for 1.84% of the portfolio, ranked #10.

Bleichroeder LP first reported a position in IMMX in Q1 2024 and has held it in 10 quarters since. 109 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

  • Bleichroeder LP held 1,000,000 shares of Immix Biopharma worth $10.3M as of Q2 2026.
  • Bleichroeder LP left its Immix Biopharma share count unchanged in Q2 2026.
  • Immix Biopharma made up 1.84% of Bleichroeder LP's portfolio in Q2 2026, its #10 holding.
  • Bleichroeder LP first reported a position in Immix Biopharma in Q1 2024 and has held it in 10 quarters since.
  • 109 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on Bleichroeder LP's 13F filing for Q2 2026, filed 13 Aug 2026.